Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies
出版年份 2021 全文链接
标题
Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 7, Pages e002444
出版商
BMJ
发表日期
2021-07-13
DOI
10.1136/jitc-2021-002444
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Enhancing Chimeric Antigen Receptor T cell Efficacy in Solid Tumors
- (2020) Giovanni Fucá et al. CLINICAL CANCER RESEARCH
- Summary of a workshop on preclinical and translational safety assessment of CD3 bispecifics
- (2020) Cris Kamperschroer et al. Journal of Immunotoxicology
- Understanding the human antibody repertoire
- (2020) Anthony R Rees mAbs
- A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies
- (2020) Dimitris Skokos et al. Science Translational Medicine
- T cell-engaging therapies — BiTEs and beyond
- (2020) Maria-Elisabeth Goebeler et al. Nature Reviews Clinical Oncology
- A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation
- (2020) Danica Chiu et al. Cancer Immunology Research
- Perspective: Designing T-Cell Engagers With Better Therapeutic Windows
- (2020) Omid Vafa et al. Frontiers in Oncology
- Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody
- (2020) Martina Geiger et al. Nature Communications
- Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
- (2019) Nathan D. Trinklein et al. mAbs
- Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T Cell-Recruiting Antibody Optimized for Cytotoxicity and Cytokine Release
- (2019) Christina L. Zuch de Zafra et al. CLINICAL CANCER RESEARCH
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Twists and turns to translating 4-1BB cancer immunotherapy
- (2019) Miguel F. Sanmamed et al. Science Translational Medicine
- Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
- (2019) Christina Claus et al. Science Translational Medicine
- CD20-TCB with obinutuzumab pretreatment as next generation treatment of hematological malignancies
- (2018) Marina Bacac et al. CLINICAL CANCER RESEARCH
- Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model
- (2018) Danielle Mandikian et al. MOLECULAR CANCER THERAPEUTICS
- The promise and challenges of immune agonist antibody development in cancer
- (2018) Patrick A. Mayes et al. NATURE REVIEWS DRUG DISCOVERY
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
- (2018) Sebastian Kobold et al. Frontiers in Oncology
- Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety
- (2018) Diego Ellerman METHODS
- p95HER2–T cell bispecific antibody for breast cancer treatment
- (2018) Irene Rius Ruiz et al. Science Translational Medicine
- Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3
- (2018) Dionysos Slaga et al. Science Translational Medicine
- The making of bispecific antibodies
- (2017) Ulrich Brinkmann et al. mAbs
- An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
- (2017) Haleh Saber et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
- (2016) M. Bacac et al. CLINICAL CANCER RESEARCH
- Computationally Designed Bispecific Antibodies using Negative State Repertoires
- (2016) Andrew Leaver-Fay et al. STRUCTURE
- Fab-based bispecific antibody formats with robust biophysical properties and biological activity
- (2015) Xiufeng Wu et al. mAbs
- Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
- (2014) Steven M Lewis et al. NATURE BIOTECHNOLOGY
- Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen
- (2010) Claudia Bluemel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A permissive geometry model for TCR–CD3 activation
- (2008) Susana Minguet et al. TRENDS IN BIOCHEMICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started